Lates News

According to the AI Flash News, Huayuan Securities released a research report on November 11th, giving Haitai Xinguang (688677.SH) a "buy" rating. The reasons for the rating mainly include: 1) High growth in revenue from medical endoscopes and optical business, with the potential of maintenance business gradually being released; 2) Steady improvement in gross profit margin, and overseas expansion opening up new space. (Daily Economic News)